According to filings with the U.S. Securities and Exchange Commission, Maia has raised $1,200,000.00 in new Seed funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

Investors in the company’s current round of funding include: Category Ventures, Canaan Partners, Alumni Ventures, and ERA

About Maia
Maia is an AI-powered revenue cycle platform purpose-built for orthopaedic practices. Maia works alongside your existing workflows to proactively code cases, improve authorization accuracy, and reduce downstream denialsbefore claims are submitted. Orthopaedic revenue cycle complexity continues to increase as procedures grow more specialized, payer rules change frequently, and staffing shortages strain administrative teams. Maia helps practices stay ahead by continuously monitoring clinical, authorization, and coding data to surface issues early and guide corrective action. Maia compares scheduled procedures, clinical documentation, and payer rules to ensure pre-authorizations match what will ultimately be billed. When mismatches are detected, Maia flags them earlyhelping teams correct issues or trigger re-authorization before services occur. Maia analyzes operative notes and documentation to surface potential coding gaps, missing specificity, or compliance risks. This supports coders by reducing rework, minimizing post-bill corrections, and improving first-pass claim accuracy. Instead of reacting to denials after the fact, Maia focuses on prevention. By identifying risk earlier in the workflow, practices can reduce avoidable denials tied to authorization errors, documentation gaps, and coding inconsistencies. Maia automates repetitive review and monitoring tasks, allowing revenue cycle and administrative staff to focus on higher-value work. This reduces manual audits, shortens turnaround times, and helps teams operate more efficiently without adding headcount. Maia is designed specifically for orthopaedic practices, supporting high-volume surgical workflows, specialty-specific coding nuances, and evolving payer requirements common in musculoskeletal care.

To learn more, visit https://usemaia.com/
Linkedin: https://www.linkedin.com/company/usemaia/

Contact:
Zach Ruhl, Chief Executive Officer
https://www.linkedin.com/in/zach-ruhl/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.